Purchases and Sales Made in Q3 2022 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q3 2022. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2022
Q3 2022
|
Public Employees Retirement Association Of Colorado
Denver, CO |
SELL
|
- |
-145K- 94.18% |
$5.79M - $9.58M
|
8.95K
$381K
|
|
|
Nov 14, 2022
Q3 2022
|
Cadian Capital Management, LP
New York, NY |
SELL
|
- |
-151K- 19.44% |
$6.05M - $10M
|
627K
$26.7M
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-186K- 33.75% |
$7.43M - $12.3M
|
365K
$15.5M
|
|
|
Nov 10, 2022
Q3 2022
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-256K- 10.38% |
$10.2M - $16.9M
|
2.21M
$94.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Suvretta Capital Management, LLC
New York, NY |
SELL
|
- |
-260K- 74.48% |
$10.4M - $17.2M
|
88.9K
$3.79M
|
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-271K- 77.05% |
$10.8M - $17.9M
|
80.7K
$3.44M
|
|
|
Nov 14, 2022
Q3 2022
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-525K- 77.2% |
$21M - $34.7M
|
155K
$6.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-834K- 82.01% |
$33.3M - $55.2M
|
183K
$7.79M
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-6.02M- 55.87% |
$241M - $398M
|
4.76M
$203M
|